Pilorid

Roman name

Pylorid

The composition and the form of

1 tablet coated liner contains ranitidine bismuth citrate 400 mg; blistere in 14 pcs. , in box 1, 2 or 4 blisters.

Pharmacokinetics

Absorption of bismuth products is less than 1% imposed doses. C_max for ranitidine, 15-60 minutes for bismuth 1-3 hours Write primarily by renal Cl. T_1/2 for ranitidine to three hours for bismuth - 5-10 days. Bismuth, unlike ranitidine gradually koumouliruet plasma equilibrium concentration is 4-nedelnogo after treatment.

Indications

Treatment of ulcers stomach and duodenal ulcer. Eradikation Helicobacter pylori, and the weakening of associated symptoms dispepsii, prevention of the recurrence of ulcers duodenal ulcer.

Pregnancy and lactation

Not recommended.

Contraindications

Hypersensitivity; Acute porphyria expressed renal insufficiency (Cl creatinine less than 10 ml / min); Child.

Side-Effects

Blackening language and faecal masses, headache, discomfort and pain in the stomach, diarrhoea or constipation, skin rashes, itching, anaphylacticskie reaction.

Patient interaction

Removals klaritromicin increases.

Overdosing

In the case of an overdose - washing stomach. Both components (ranitidine and bismuth) can be removed from the blood by the kidney.

Precautions

Before the start of treatment in patients with gastric ulcers stomach should be deleted malignizatiou.

Storage conditions

List B. The temperature is not above 30 ° C

Shelf life

3 years

The registration

009,290 (Ann.2002)

Directory → Intermedianta → Gistaminergicakie funds → Gistaminolitiki → H_2-antigistaminne funds → Pilorid